Xylocaine (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Xylocaine drug offered from Fresenius Kabi USA, LLC. This Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
NON-PROPRIETARY NAME: | LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE |
SUBSTANCE NAME: | LIDOCAINE HYDROCHLORIDE ANHYDROUS; EPINEPHRINE BITARTRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |
ROUTE: | INFILTRATION; PERINEURAL |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2010-08-12 |
END MARKETING DATE: | 0000-00-00 |
Xylocaine HUMAN PRESCRIPTION DRUG Details:
Item Description | Xylocaine from Fresenius Kabi USA, LLC |
LABELER NAME: | Fresenius Kabi USA, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5; .005(mg/mL; mg/mL) |
START MARKETING DATE: | 2010-08-12 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63323-481_d41a176f-eb4a-4261-ab83-f256f7d1fc6c |
PRODUCT NDC: | 63323-481 |
APPLICATION NUMBER: | NDA006488 |
Other LIDOCAINE HYDROCHLORIDE ANHYDROUS; EPINEPHRINE BITARTRATE Pharmaceutical Manufacturers / Labelers: